Literature DB >> 22300228

Neurocysticercosis: the enigmatic disease.

Svetlana Agapejev1.   

Abstract

Neurocysticercosis (NCC) is an infection of the central nervous system (CNS) caused by the metacestode larval form of the parasite Taenia sp. Many factors can contribute to the endemic nature of cysticercosis. The inflammatory process that occurs in the tissue surrounding the parasite and/or distal from it can result from several associated mechanisms and may be disproportionate with the number of cysts. This discrepancy may lead to difficulty with the proper diagnosis in people from low endemic regions or regions that lack laboratory resources. In the CNS, the cysticerci have two basic forms, isolated cysts (Cysticercus cellulosae=CC) and racemose cysts (Cysticercus racemosus=CR), and may be meningeal, parenchymal, or ventricular or have a mixed location. The clinical manifestations are based on two fundamental syndromes that may occur in isolation or be associated: epilepsy and intracranial hypertension. They may be asymptomatic, symptomatic or fatal; have an acute, sub-acute or chronic picture; or may be in remission or exacerbated. The cerebrospinal fluid (CSF) may be normal, even in patients with viable cysticerci, until the patients begin to exhibit the classical syndrome of NCC in the CSF, or show changes in one or more routine analysed parameters. Computed tomography (CT) and magnetic resonance imaging (MRI) have allowed non-invasive diagnoses, but can lead to false negatives. Treatment is a highly controversial issue and is characterised by individualised therapy sessions. Two drugs are commonly used, praziquantel (PZQ) and albendazole (ABZ). The choice of anti-inflammatory drugs includes steroids and dextrochlorpheniramine (DCP). Hydrocephalus is a common secondary effect of NCC. Surgical cases of hydrocephalus must be submitted to ventricle-peritoneal shunt (VPS) immediately before cysticidal treatment, and surgical extirpation of the cyst may lead to an absence of the surrounding inflammatory process. The progression of NCC may be simple or complicated, have remission with or without treatment and may exhibit symptoms that can disappear for long periods of time or persist until death. Unknown, neglected and controversial aspects of NCC, such as the impaired fourth ventricle syndrome, the presence of chronic brain oedema and psychic complaints, in addition to the lack of detectable glucose in the CSF and re-infection are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22300228     DOI: 10.2174/1871524911106040261

Source DB:  PubMed          Journal:  Cent Nerv Syst Agents Med Chem        ISSN: 1871-5249


  11 in total

1.  Neurocysticercosis: Five new things.

Authors:  Arturo Carpio; Agnès Fleury; W Allen Hauser
Journal:  Neurol Clin Pract       Date:  2013-04

2.  Serodiagnosis of human neurocysticercosis using antigenic components of Taenia solium metacestodes derived from the unbound fraction from jacalin affinity chromatography.

Authors:  Gleyce Alves Machado; Heliana Batista de Oliveira; Margareth Leitão Gennari-Cardoso; José Roberto Mineo; Julia Maria Costa-Cruz
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-05       Impact factor: 2.743

3.  Commentary.

Authors:  Rodrigo Ramos-Zúñiga
Journal:  J Neurosci Rural Pract       Date:  2013-01

4.  Neurocysticercosis: About 5 reported Thai cases.

Authors:  Svetlana Agapejev
Journal:  J Neurosci Rural Pract       Date:  2015 Oct-Dec

5.  Racemose cysticercosis: A summary of 5 reported Thai cases.

Authors:  Somsri Wiwanitkit; Viroj Wiwanitkit
Journal:  J Neurosci Rural Pract       Date:  2015 Jul-Sep

6.  [Diagnostic value of CT scan in neurocysticercosis in Lome].

Authors:  Lantam Sonhaye; Mazamaesso Tchaou; Abdoulatif Amadou; Kouméabalo Assih; Berésa Kolou; Komlavi Adjenou; Koffi N'dakena
Journal:  Pan Afr Med J       Date:  2015-01-26

7.  A Case of Cerebral Cysticercosis in Thailand.

Authors:  Samasuk Thammachantha; Ratana Kunnatiranont; Pongwat Polpong
Journal:  Korean J Parasitol       Date:  2016-12-31       Impact factor: 1.341

8.  Treatment of racemose neurocysticercosis.

Authors:  Samuel G McClugage; Rachael A Lee; Bernard C Camins; Juan J Mercado-Acosta; Martin Rodriguez; Kristen O Riley
Journal:  Surg Neurol Int       Date:  2017-08-01

9.  Antibody Banding Patterns of the Enzyme-Linked Immunoelectrotransfer Blot and Brain Imaging Findings in Patients With Neurocysticercosis.

Authors:  Gianfranco Arroyo; Silvia Rodriguez; Andres G Lescano; Karen A Alroy; Javier A Bustos; Saul Santivañez; Isidro Gonzales; Herbert Saavedra; E Javier Pretell; Armando E Gonzalez; Robert H Gilman; Victor C W Tsang; Hector H Garcia
Journal:  Clin Infect Dis       Date:  2018-01-06       Impact factor: 9.079

Review 10.  Differential diagnosis of multiple sclerosis in Latin America.

Authors:  Y D Fragoso; F G Elso; A Carrá
Journal:  Mult Scler J Exp Transl Clin       Date:  2017-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.